Xpedite Diagnostics

What Xpedite Diagnostics does

Xpedite Diagnostics GmbH is a Hallbergmoos, Germany-based biotechnology company founded in November 2020 by Dr. Andy Wende that develops, manufactures, and supplies rapid DNA and RNA extraction kits and supporting instrumentation built on a proprietary Reverse Purification chemistry. The technology binds cellular debris and inhibitors to coated magnetic beads while leaving nucleic acids in solution, eliminating centrifugation, multiple wash steps, and hazardous reagents and enabling extraction in as little as five minutes. The portfolio comprises the SwiftX™ line of application-specific kits (DNA, Virus, Sepsis, Blood Genomic, cfDNA, Media, ParaBact, Water, Grinding Tools), the recently introduced ClassiX™ line of routine molecular biology consumables led by ClassiX™ CleanUp, the SwiftXtractor™ SL benchtop automated extraction platform, magnetic racks, and resale partner products (Axxin instruments, RAA amplification kits). Five of nine kits hold CE-IVD certification under IVD Regulation (EU) 2017/746, and the company is ISO 9001:2015 and ISO 13485:2016 certified.

The company sells consumables, instruments, and services directly from Germany (shipping via DHL Express or FedEx) and through newly established regional distributors in Benelux (Go-fin Molecular Technologies) and Italy (DBA Italia), with active distributor recruitment in other territories. End customers include academic and clinical research laboratories, veterinary diagnostic labs, and public-health reference labs across 28 countries (e.g., Iowa State University, NYU Langone Health, Natural History Museum UK, CEDROB/Cedlab Poland, National Reference Laboratory for Dermatophytes), with over 500,000 cumulative extractions across 100+ customers supported by 50+ scientific publications. Revenue streams combine one-time kit and instrument sales, OEM manufacturing and technology licensing, contract development services, and IVDR regulatory consulting. Capitalization to date consists of approximately €100K of non-dilutive grant funding (LfA Förderbank Bayern, 2021) plus an IraSME grant for the VISTA veterinary co-development project with Swiss partner diaxxo AG, with no disclosed VC/PE participation.

Name

Xpedite Diagnostics

Legal name

Xpedite Diagnostics GmbH

Website

https://xpedite-dx.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Xpedite Diagnostics GmbH is a German biotechnology company that develops and supplies rapid DNA/RNA extraction kits, automated instrumentation, and related services based on proprietary Reverse Purification chemistry for diagnostic, veterinary, and research laboratories across 28 countries.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics Reagents

NAICS

Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Molecular POCT / NAAT Systems (PCR/Isothermal platforms & cartridges) (HLAHAOAI)

Keywords

• Nucleic acid extraction
• DNA RNA extraction kits
• Point-of-care diagnostics
• Molecular sample preparation
• Magnetic bead purification

Headquarters

HQ city

Hallbergmoos

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Product Sales (Kits and Instruments): Sale of SwiftX™ DNA/RNA extraction kits, ClassiX™ products, instrumentation including SwiftXtractor™ SL, magnetic racks, and accessories. Products available as RUO (Research Use Only) and CE-IVD certified versions.
2. Contract Development Services: Expert support for sample preparation development. Research team with 25+ years experience in molecular biology and diagnostics provides contract development for specific DNA/RNA extraction solutions tailored to customer requirements.
3. OEM Manufacturing: Licensing of SwiftX technology and OEM manufacturing of kits under customer brand name. Offers both licensing-in of existing products and OEM manufacturing services.
4. IVDR Regulatory Consulting Services: Regulatory consulting for IVD manufacturers and laboratories including IVDR compliance, technical file completion/review, gap analysis, mock audits, and supplier audits for CE-IVD certification.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Xpedite Diagnostics researches, develops, manufactures, and supplies rapid DNA and RNA extraction kits (SwiftX™ and ClassiX™ product lines) and supporting instrumentation (SwiftXtractor™ SL automated platform, magnetic racks, grinding tools) built on proprietary Reverse Purification magnetic bead chemistry. The products target diagnostics laboratories, research institutions, point-of-care settings, and veterinary diagnostics, enabling nucleic acid extraction in as little as 5 minutes without centrifugation or hazardous chemicals, with downstream compatibility with qPCR, ddPCR, Nanopore sequencing and NGS.

Product overview

Xpedite Diagnostics offers a comprehensive portfolio of rapid DNA/RNA extraction solutions built around proprietary Reverse Purification technology, which eliminates the need for centrifugation, hazardous chemicals, and complex equipment. The core SwiftX™ product line includes specialized extraction kits for diverse sample types: SwiftX™ DNA for versatile extraction from various specimens, SwiftX™ Sepsis for ultrasensitive whole-blood pathogen capture, SwiftX™ Virus for rapid viral extraction from serum/plasma, SwiftX™ cfDNA for cell-free DNA from plasma and urine, SwiftX™ Blood Genomic for blood samples, and SwiftX™ Media for transport media. The ClassiX™ product line expands into everyday molecular biology consumables, starting with ClassiX™ CleanUp for magnetic bead-based PCR/NGS purification. Supporting instrumentation includes the SwiftXtractor™ SL automated large-volume extraction platform, magnetic racks, and SwiftX™ Grinding Tools. Partner products include RAA (Recombinase Aided Amplification) detection kits for fluorescence, lateral-flow, and end-point modalities, plus Axxin portable detection instruments. Services encompass contract development, OEM manufacturing, and IVDR regulatory consulting. All extracted nucleic acids are validated for downstream compatibility with qPCR, ddPCR, Nanopore sequencing, and NGS platforms.

Differentiator

Problem solved

Functional benefit

Brands

• SwiftX: DNA and RNA extraction kits using proprietary reverse purification technology for rapid molecular diagnostics and point-of-care testing
• ClassiX
• SwiftXtractor

Products and services

• SwiftX™ DNA Versatile DNA and RNA extraction kit using cell capture and Reverse Purification technology for extraction of genomic and pathogen nucleic acids from a broad range of specimen types; solid samples ready for amplification in as little as 5 minutes and liquid specimens in approximately 15 minutes without centrifugation.
• SwiftX™ Sepsis Ultrasensitive pathogen cell-capture DNA extraction kit for whole-blood analysis; isolates bacterial and fungal DNA directly from 10 mL of whole blood in under 45 minutes using selective microbial cell-capture chemistry for culture-free sepsis research.
• SwiftX™ Virus One-step viral DNA and RNA extraction kit for serum and plasma samples; extracts viral genetic material in less than 6 minutes at point-of-care without complex equipment.
• SwiftX™ cfDNA Cell-free DNA extraction kit that extracts cfDNA from plasma and urine samples through rapid cell-free concentration in minutes, supporting cancer diagnostics from complex samples.
• SwiftX™ Blood Genomic Genomic DNA extraction kit for extraction from 10 µL to 1 mL blood volumes, enabling rapid diagnosis of genetic conditions and blood-based diseases.
• SwiftX™ Media One-step enzymatic lysis vRNA extraction kit for swab and transport media samples; extracts DNA and RNA in 10 minutes, available in both RUO and CE-IVD versions.
• SwiftX™ Water DNA extraction kit variant designed for water samples, part of the SwiftX product family for various specimen types including environmental and water-based surveillance.
• SwiftX™ ParaBact SwiftX extraction product designed for bacterial sample preparation, part of the specialized disease and application-specific product line for parasitology and bacteriology workflows.
• EUROArray SwiftX-traction EUROArray product with SwiftX-traction technology for extracting pathogen DNA from a wide range of samples in under 20 minutes; CE-IVD certified product distributed via collaboration with EUROIMMUN.
• ClassiX™ CleanUp Magnetic bead-based DNA purification reagent for post-PCR and NGS workflow clean-up; SPRI-based chemistry with bind-wash-elute workflow completing in ≤15 minutes with tunable bead-to-sample ratios from 1.0× to 1.8× for fragment size selection; priced at €109 for 10 mL.
• SwiftXtractor™ SL Automated nucleic acid extraction instrument and first compact benchtop platform for automated large-volume extraction; processes sample input volumes from 200 µL up to 40 mL and concentrates purified DNA/RNA into eluates as low as 50 µL in a single automated run for wastewater surveillance, bloodstream pathogen detection, and urine-based STI screening.
• Magnetic Racks Magnetic separation and purification racks for nucleic acid purification using proprietary reverse purification technology with magnetic beads for superior sample quality; sold as accessories to support kit-based workflows.
• SwiftX™ Grinding Tools Purpose-built accessories for rapid mechanical disruption of solid biological samples; supports reproducible homogenization for environmental and vector-borne pathogen surveillance applications without slowing time-critical workflows.
• Contract Development & OEM Manufacturing Services Contract development services leveraging the SwiftX Toolbox of buffers, liquids, particles, solid materials, and enzymes for rapidly developing new DNA/RNA extraction solutions; also offers licensing of SwiftX technology and OEM manufacturing under customer brand name.
• IVDR Regulatory Services Regulatory consulting for IVD manufacturers and laboratories including IVDR gap analysis of Quality Management Systems, IVD Technical File completion and review, mock audits, supplier audits, and IVDR whitepaper for laboratory-developed tests.

Quantifiable outcome

• DNA/RNA extraction completed in 5+ minutes compared to hours for traditional methods
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• diaxxo AG (Switzerland)coreStrategic or Co-development Partner · 25 June 2026Joint IraSME-funded project VISTA (Versatile Integrated Sample-To-Answer Diagnostics) developing a universal DNA/RNA purification solution for veterinary diagnostics. The project builds on Xpedite's DNA/RNA extraction expertise and diaxxo's integrated M2 sample-to-answer platform. Target is chaotrope-free, solvent-free, ambient temperature-stable chemistry for sample volumes from 200µL to 20mL.
• Go-fin Molecular TechnologiescoreChannel Partner/ Reseller/ Distributor · 17 March 2026Distribution partnership bringing Xpedite Diagnostics' innovative rapid nucleic acid extraction technologies to laboratories in Netherlands, Belgium and Luxembourg. Partner provides faster logistics, simplified procedures, and dependable local support for Benelux customers.
• DBA ItaliacoreChannel Partner/ Reseller/ Distributor · 20 January 2026Distribution partnership bringing Xpedite Diagnostics' innovative rapid nucleic acid extraction technologies closer to Italian laboratories. Partner enables faster workflows, simplified logistics, and dependable local support for Italian market.
• German Network against Neglected Tropical Diseases (DNTDs)minorStrategic or Co-development PartnerPartnership supporting advancement of innovative and efficient nucleic acid extraction for neglected tropical diseases. Part of broader funding and partnership network supporting company R&D.
• EUROIMMUNminorStrategic or Co-development PartnerListed as funding and partnership supporter for advancing innovative nucleic acid extraction chemistries and protocols. Collaboration in academic and industry context.
• SeegeneminorStrategic or Co-development PartnerListed as funding and partnership supporter for advancing innovative nucleic acid extraction chemistries and protocols. Collaboration in academic and industry context.
• QT Biotech Co., Ltd.minorStrategic or Co-development PartnerListed as funding and partnership supporter for advancing innovative nucleic acid extraction chemistries and protocols. Collaboration in academic and industry context.

Scale indicators8 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Qiagen: Global leader in nucleic acid extraction (QIAamp, QIAcube) and molecular diagnostics. Founder Dr. Wende was a former Qiagen scientist, and the SpeedXtract product was originally a Qiagen kit that Xpedite revived — making Qiagen the most directly comparable competitor in chemistry, scale, and existing OEM/kits business model.
• Bio-Techne: Public life-sciences tools company (includes R&D Systems, Novus Biologicals, ProteinSimple). Sells nucleic acid extraction and molecular biology consumables across a broad catalog that overlaps the ClassiX line and routine molecular biology use cases.
• Thermo Fisher Scientific: Largest life-science tools player, dominating nucleic acid extraction via the KingFisher, MagMAX and PureLink product lines. Anchors the addressable market but is less specialized for rapid, equipment-free, POCT workflows where Xpedite differentiates.
• Revvity (formerly PerkinElmer): Large life sciences platform with chemagic automated DNA/RNA extraction instruments and reagents, plus an IVD/diagnostics business. Competes in the benchtop-instrument extraction niche that Xpedite entered with SwiftXtractor SL, with far greater global scale.

Direct peers

• Zymo Research: Privately held US competitor specializing in nucleic acid purification (Quick-DNA/RNA kits) and microbiome/wastewater workflows. Overlaps Xpedite on the same kit-plus-bead chemistry, wastewater surveillance use case, and similar mid-sized company growth profile.
• Omega Bio-tek: Privately held US reagent manufacturer focused on magnetic-bead-based nucleic acid purification kits (E.Z.N.A., Mag-Bind). Similar specialization depth, similar mid-sized competitor footprint to Xpedite.
• Promega: Manufacturer of Maxwell and ReliaPrep DNA/RNA extraction systems and reagents. Competes on the same kit-plus-automated-instrument model and on clinical research/IVD-adjacent use cases; comparable in revenue scale and product breadth to Xpedite's aspiration.
• Macherey-Nagel (NucleoSpin): German-headquartered manufacturer of NucleoSpin DNA/RNA extraction kits and the NucleoMag bead-based platform. Closely comparable on geographic origin (Düren, Germany), magnetic-bead/chaotrope chemistry, and the kit-plus-instrument consumable model that Xpedite mirrors.
• Analytik Jena: German-based (now part of Endress+Hauser) life science instrument and reagent supplier with the CytoDirect and InnuPure extraction product lines. Comparable on German origin, kit-plus-instrument offering, and CE-IVD regulated workflow position.

Emerging players

• diaxxo AG: Swiss molecular diagnostics start-up with an integrated M2 sample-to-answer platform. Currently a co-development partner on the IraSME-funded VISTA project, making them a directly linked emerging peer in decentralized molecular testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/XpediteDx
• YouTubeyoutube.com/@xpeditediagnostics1100
• LinkedInlinkedin.com/company/xpedite-diagnostics-gmbh

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xpedite Diagnostics